Analyzing biotech clinical trial risk: Frank David, founder of Pharmagellan
Рет қаралды 4,698
Күн бұрынFrank David joins us to walk through a framework for estimating clinical trial probability of success.
Check out Frank's books on analyzing clinical trials and biotech forecasting and valuation here: www.pharmagellan.com/books
And check out Frank's blog post on his framework for clinical triak risk here: www.pharmagellan.com/blog/cli...
@ofirgoldberger9274 Жыл бұрын
Nice video! For advanced therapies such as cell and gene therapy one should also consider reimbursement risk (beta-cel in the EU) and manufacturing risk / COGS (kymriah).
@snowxu9214 2 жыл бұрын
This is an amazing video!
@ahmedalaofi2756 2 жыл бұрын
Thank you so much for this video. I appreciate your efforts.
@pabloalonso5798 2 жыл бұрын
Amazing video!
@spyrex3988 Жыл бұрын
The thing with this strategy is how 90% win rate returns would be gone and probably go in debt if u encountered the 10% loss once
Nikita Zdradovskiy
Рет қаралды 6 МЛН
Scary Teacher 3D Gaming
Рет қаралды 55 МЛН
Bay Bridge Bio
Рет қаралды 2,5 М.
FirstThought
Рет қаралды 379
Rj Mobile 01
Рет қаралды 12 МЛН
Immersed
Рет қаралды 4,9 МЛН